3 курс / Общая хирургия и оперативная хирургия / Зейналов_Э_К_Тактика_хирургического_лечения_больных_с_ИБС_и_рецидивирующей

patient data from randomized clinical trials.// J. Thorac. Cardiovasc. Surg.-

2005.-Vol. 130(2).- P.512–519.

124.Metha G.S., La Par D.J, Bhamidipati C.M., Kern J.A., Kron I.L., Upchurch G.R., Ailawadi G. Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting.// Surgery. – 2012.- Vol. 152, Issue 1- P.5–11.

125.Meuwissen M. Stent inflammationstent footprint in restenotic tissue retrieved by directional atherectomy./ van der Wal AC, de Winter RJ, Koch KT, Becker AE, Piek JJ. // Circulation. – 2002 – Vol. 106. – P.1176-1177.

126.Molina JA, Heng BH. Global trends in cardiology and cardiothoracic surgery-an opportunity or threat? Ann. Acad. Med. Singapore 38(6), 541-545, 2009

127.Moreno PR. Macrophage infiltration in acute coronary syndromesimplications for plaque rupture./ Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. // Circulation. – 1994. – Vol. 90. – P.775-778.

128.Negargar S., Anvari S., Abbasi K., et al. Immediate postoperative complication in patients undergoing CABG; Investigating the role of prior coronary stenting. //J. Cardiovasc. Thorac Res. – 2014.- Vol. 6(4).-P. 229-234.

129.Park HJ, Kim HY, Lee JM, et al. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion — CAtholic Total Occlusion Study (CATOS) trial. Circ J- . 2012. – Vol. 76(4). – P.868-

130.Porto I. et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention. 2006.

131

131.Qureshi S.H., De Belder M., Akowuah E. Assessing Safety of CABG in the Era Post Primary PCI, an Outcome Analysis of STEMI Population. //World Journal of Cardiovascular Surgery. – 2013. –Vol.3. – P.15-22.

132.Rao C, De Lisle R, Chikwe J, Pepper J, Skapinakis P, Aziz O, et al. Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study. //Ann Thorac Surg.- 2008.- Vol. 85.- P.501-507.

133. Rao C., Aziz O., Panesar SS., Jones C., Morris S., Darzi A., Athanasiou T. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.// BMJ. – 2007. – P.334:62.

134.RESTORE Investigators Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplastyRandomized Efficacy Study of Tirofiban for Outcomes and REstenosis. The RESTORE Investigators //Circulation - 1997.- Vol. 96.- P.1445-1453.

135.Rosamond W, Flegal K, Friday G, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics—2007 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. //Circulation. – 2007. – Vol.115. – P.169-171.

136.Sakaguchi G., Shimamoto T., Komiya T. Impact of repeated percutaneous coronary intervention on long-term survival after subsequent coronary artery bypass surgery.// J. Cardiothorac. Surg.- 2011.- Vol. 6. - P.

107.

137.Sanchez E, Cid-Cumplido M, Moreno E, S. Tarnini I, Khan I, Pineda T, Gonzales J.R. Previous Percutaneous Coronary Intervention Does Not

132

Increase In-Hospital Mortality After Surgical Revascularization: Analysis of

63420 Cases //Argentine Journal of Cardiology.- 2013. Vol. 81.- P.208-214.

138.Santini F, Casali G, Lusini M, D'Onofrio A, Barbieri E, Rigatelli G, Franco G, Mazzucco A. Mid-term results after extensive vein patch reconstruction and internal mammary grafting of the diffusely diseased left anterior descending coronary artery//. Eur J Cardiothorac Surg.- 2002. – Vol.

21.– P. 1020–1025.

139.Selvanayagam JB. et al. Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study.// Circulation. – 2007. – Vol.116 –

P.1458-1464.

140.Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.// N. Engl. J. Med.- 2009.- V.360(10).-P. 961–972.

141.Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial // J Am Coll Cardiol/ - 2005. – Vol.46:. – P.75-581.

142.Shin DI, Kim PJ, Seung KB, et al. Drag-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.// Int Heart О. - 2007. – Vol.48. – P.553-67.

143.Shroyer A.L., Plomondon M.E., Grover F.L., et al. The 1996 coronary artery bypass risk model: The Society of Thoracic Surgeons adult cardiac database// Ann Thorac Surg. – 1999. – V. 67. – P. 1205-1208.

144.Society of Thoracic Sugeons. Spring 2007 Report–Adult Cardiac Database Executive Summary. 2007.

145.Soran O.,, Manchanda A., Schueler S. Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a

133

current perspective. //Interact CardioVasc Thorac Surg. – 2009. – V.8. – P.

666.

146.SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial// Lancet.- 2002.-V. 360(9338). P. 965–970.

147.Thadani U. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris// Cor Artery Dis. – 2004. – Vol.15(Suppl 1). –P. 1-4.

148.Thielmann M, Leyh R, Massoudy P, Neuhäuser M, Aleksic I, Kamler

M, et al. Prognostic significance of multiple previous percutaneous interventions in patients undergoing elective coronary artery bypass surgery. //Circulation.- 2006.- Vol. 114(suppl I).- P.I441-I447.

149.Thielmann M, Neuhäuser M, Knipp S, Kottenberg-Assenmacher E, Marr A, Pizanis N, et al. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. //J Thorac Cardiovasc Surg.- 2007.-Vol.134.-P.470-476.

150.Tokoz H., Sanioglu S., Sokullu O., Hasdtmir H., Ozler A., Aka S.A. Semiurgent CABG after Successful PTCA: Should a Patent Stended Coronary Artery Be By-Passed? //Open J. Torac. Surg.- 2012.- Vol.2. – P.46-51.

151.Toutouzas K, Colombo A, Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J. 2004. – Vol. 25. – P. 1679–1687.

152.Tovar E.A, Borsari A. Effects of surgical manipulation on coronary stents: should surgical strategy be altered? //Ann Thorac Surg – 1997. –

Vol.63 – P.37-40.

153.Tovar EA, Blau N, Borsari A, Landa DW, Packer JM. Severe

deformity of a Palmaz-Schatz stent after normal surgical manipulation// Ann

134

Thorac Surg. – 1997. – Vol. 63, - P. 220-221.

154.Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, Airoldi F, Montorfano M, Michev I, Colombo A. Multiple overlapping drugeluting stents to treat diffuse disease of the left anterior descending coronary artery.// J Am Coll Cardiol. – 2005. – Vol. 45. – P.1570–1573.

155.V., Schwann T A., Yammine M. B., Abdul-Karim M. El-Hage-

Sleiman, El Zein M. H., Kabour A., Engoren M.C.,Impact of prior intracoronary stenting on late outcomes of coronary artery bypass surgery in diabetics with triple-vessel disease. //J Thorac Cardiovasc. Surg.- 2015. - Vol. 149 Iss. 2, .

156.Van den Brule J. M.D. Risk of coronary surgery for hospital and early morbidity and mortality after initially successful percutaneous intervention. L. Noyez, and F. W.A. //Verheugt Interactive CardioVascular and Thoracic Surgery.- 2005.- Vol. 4(2).- P. 96 - 100.

157.Velicki L., Does Prior Coronary Stenting Compromise Future Coronary Surgery?// Interv. Cardiol. - 2013.- Vol. 5(1).- P. 93-100.

158.Versaci F. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. // Am J Cardiol. –

2000. – Vol.85. – P.92-95.

159.Warnica JW, Gilst WV, Baillot R et al. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial – design and rationale. //Can. J. Cardiol.- 2002.-Vol. 18(11).- P. 1191–1200.

160.Wei G, Fang Y, Yaqi R, Lin C, Ningfu W. Clinical outcomes of zotarolimus-eluting stents versus the first generation sirolimus-eluting stents and paclitaxel-eluting stents: a meta-analysis of randomized trials.// Int J Cardiol - 2012. – Vol. 157(1). – P.152-156. Yap CH, Yan BP, Akowuah E et

135

al. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?. //JACC Cardiovasc. Interv.-

2009.- Vol.2(8).- P758–764.

163.Lozano R., Naghavi M., Foreman K.,et al. Global and regional mortality from 235 causes of death for 20 age group in 1990 - 2010: a systematic analysis for the Global Burden of Disease Study 2010 // Lancet. - 2012; Vol. 380.’- P. 2095-2128.

164.Tran H.A., Barnett S.D., Hunt S.L., et al. The effect of previous coronary artery stenting on short-and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus. J.Thorac. Cardiovasc. Surg.-2009.- Vol. 138.- P.316-323

165.Fajadet J., Morice M.C., Bode C., et al. Maintenance of long –term clinical benefit with sirolimus-eluting coronary stents: three-year resalys of the RAVEL trial.// Circulation|. – 2005. –Vol. 111(8); P. 1040 - 4.Ellis SG,

Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997.-= Vol. 95.- P. 2479–2484.

169.Ben-Gal Y, Mohr R, Uretzky G, Medalion B, Hendler A, Hansson N, et al. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2006.-Vol.132.- P.861-866.

170.Cameron D.E., Stinson D.C., Greene P.C., Gardner T.J. Surgical standby for percutaneous transluminal coronary angioplasty: a survey of patterns of practice. Ann Thorac Surg 1990ю-Vol.50.- P.35-39.

171.Stolker J.M., Cohen D.J., Kennedy K.F., Pencina M.J., Lindsey J.B., et al. repeat revascularization after contemporary percutaneous coronary intervention : an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first yaer/Circ. Cardiovasc Interv. 2012

–Vol. 5.- P.772-778.

136

172. Mohr F.W., Morice M.C., Kappetein A/P., Feldman T.E., Stahle E., Colombo A., et al. Coronary artery bypass graft bsurgery versus percutaneous coronary intervention in patients with three-vessel disease and main coronary disease: 5-yaer follow-up of the randomized? Clinical SINTAX trial ? Lancet.- 2013. –Vol. 381.- P.629-638.

137